In summary, our study reaffirms the significance of CALML6 and the EP4/CALML6/CaMKK2/AMPK signaling pathway in OSCC progression, offering a comprehensive overview of their roles in cancer cell migration and suggesting them as potential targets for OSCC therapy. Here, CALML6 is linked to cancer.